| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.5 | 0.08 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.35 | 0.2 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.23 | 0.009 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.16 | 0.04 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.15 | 0.6 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.05 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.1 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |